Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
DataMeds AI, Inc.Bullish
DataMeds AI has regained compliance with Nasdaq Listing Rule 5550(b)(1) after receiving notification that it now meets the minimum stockholders' equity requirement of $2.5 million. The company, which faced potential delisting in April due to equity deficiencies, has successfully resolved the issue through recent capital improvements.…more
DataMeds AI, Inc.
DataMeds AI has entered into an exclusive IP license agreement with REBOOT Health AI for its GLP-1 weight management platform, issuing 666,667 shares of common stock as consideration. The company believes it has regained compliance with the Nasdaq minimum stockholders' equity requirement of $2.5 million following recent debt extinguishments and equity issuances, and is currently awaiting formal confirmation from the exchange.…more
DataMeds AI, Inc.
DataMeds AI has improved its financial position by repurchasing and extinguishing 364,099 shares of common stock and settling approximately $19 million in liabilities. Additionally, the company issued 666,667 shares of common stock to REBOOT Health AI as part of a new license agreement for a care management platform. These actions have confirmed that the company's stockholders' equity exceeds $2.5 million.…more
38 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
DataMEDS AI Launches 'Health Lives Here' Respiratory Program for 6,500 Pharmacies…more
DataMEDS AI is launching the 'Health Lives Here' respiratory health program across its network of over 6,500 independent pharmacies starting in Q4 2026. As the announcement lacks specific financial targets or revenue impact details, the market outlook remains neutral.…more
●●●●●●●● ●●●●● ●●●●●●
DataMeds AI has entered into a non-binding letter of intent to acquire various intellectual property assets and expand its healthcare operations. The transaction remains subject to due diligence and the execution of definitive agreements, with no guarantee of completion.…more
●●●●●●●● ●●●●● ●●●●●●
DataMeds AI has regained compliance with Nasdaq's minimum stockholders' equity requirement. The company remains subject to potential delisting if it fails to maintain these standards in future periodic reports.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.